author-photo

Nadia Solovieff

Boston University
Novartis

50

Papers

1969

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Abstract GS1-04: Correlative biomarker analysis of intrinsic subtypes and efficacy across the MONALEESA Phase III studies

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Abstract A031: Association of tumor DNA in circulation with clinical characteristics and treatment response in HR+/HER2− advanced breast cancer

2019 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Genomic Influences on Self-Reported Childhood Maltreatment

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT143: Baseline circulating tumor DNA (ctDNA) analysis in Asian women with HR+/HER2- advanced breast cancer (ABC) receiving ribociclib + endocrine therapy in the Phase Ib MONALEESASIA trial

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Abstract A029: Biomarker analysis in HR+, HER2-, locally advanced, or metastatic breast cancer patients treated with buparlisib: results from BELLE-3

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (19)
Abstract A029: Biomarker analysis in HR+, HER2-, locally advanced, or metastatic breast cancer patients treated with buparlisib: results from BELLE-3

2018 Biomarkers
Show All
- Source
- Cite
- Save
Citations (0)